These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15641470)

  • 1. [Obesity and steatohepatitis. Histologic aspects].
    Pichardo-Bahena R; Paz-Gómez FJ; Estrada-Villaseñor EG
    Gac Med Mex; 2004; 140 Suppl 2():S33-40. PubMed ID: 15641470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose tissue as an endocrine organ.
    Kershaw EE; Flier JS
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2548-56. PubMed ID: 15181022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
    Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
    Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis.
    Miele L; Forgione A; Hernandez AP; Gabrieli ML; Vero V; Di Rocco P; Greco AV; Gasbarrini G; Gasbarrini A; Grieco A
    Eur Rev Med Pharmacol Sci; 2005; 9(5):273-7. PubMed ID: 16231589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adipose tissue dysfunction in obesity.
    Blüher M
    Exp Clin Endocrinol Diabetes; 2009 Jun; 117(6):241-50. PubMed ID: 19358089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells.
    Fain JN
    Vitam Horm; 2006; 74():443-77. PubMed ID: 17027526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of NASH: animal models.
    London RM; George J
    Clin Liver Dis; 2007 Feb; 11(1):55-74, viii. PubMed ID: 17544972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease: further expression of the metabolic syndrome.
    Tarantino G; Saldalamacchia G; Conca P; Arena A
    J Gastroenterol Hepatol; 2007 Mar; 22(3):293-303. PubMed ID: 17295757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Obesity and non-alcoholic steatohepatitis].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
    Gac Med Mex; 2004; 140 Suppl 2():S67-72. PubMed ID: 15641474
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic microcirculation in fatty liver disease.
    Farrell GC; Teoh NC; McCuskey RS
    Anat Rec (Hoboken); 2008 Jun; 291(6):684-92. PubMed ID: 18484615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Nonalcoholic steatohepatitis: pathogenesis and treatment].
    Park SH
    Korean J Hepatol; 2008 Mar; 14(1):12-27. PubMed ID: 18367854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of disease: adipocytokines and visceral adipose tissue--emerging role in nonalcoholic fatty liver disease.
    Schäffler A; Schölmerich J; Büchler C
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jun; 2(6):273-80. PubMed ID: 16265231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L; Rubbia-Brandt L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obesity and alcoholic liver disease.
    Diehl AM
    Alcohol; 2004 Aug; 34(1):81-7. PubMed ID: 15670669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Adipocytokins, obesity and development of type 2 diabetes].
    Lacquemant C; Vasseur F; Leprêtre F; Froguel P
    Med Sci (Paris); 2005 Dec; 21 Spec No():10-8. PubMed ID: 16598899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease and hepatitis C infection.
    Bondini S; Younossi ZM
    Minerva Gastroenterol Dietol; 2006 Jun; 52(2):135-43. PubMed ID: 16557185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive and non-invasive investigations for non-alcoholic steatohepatitis: the benefit of histology.
    Ahmed MH
    Scand J Gastroenterol; 2005 Oct; 40(10):1260. PubMed ID: 16165706
    [No Abstract]   [Full Text] [Related]  

  • 18. Non-alcoholic steatohepatitis.
    Das K; Kar P
    J Assoc Physicians India; 2005 Mar; 53():195-9. PubMed ID: 15926603
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of metabolic syndrome, nonalcoholic fatty liver disease and chronic hepatitis C.
    Rafiq N; Younossi ZM
    Expert Rev Gastroenterol Hepatol; 2008 Apr; 2(2):207-15. PubMed ID: 19072356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From big fat cells to high blood pressure: a pathway to obesity-associated hypertension.
    Pausova Z
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):173-8. PubMed ID: 16481885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.